See All Slides - tctmd.com

Slides

The Frequency and Etiology of Readmission in the 30 days After Percutaneous Coronary Intervention

Presentation TCT 2012

The Frequency and Etiology of Readmission in the 30 days After Percutaneous Coronary Intervention

Presenter: Gregory W. Yost, Stefanie L. Puher, Thomas D. Scott, Kimberly A. Skelding, Donald Nardone, John McB Hodgson, Peter B. Berger, James C. Blankenship

January 03, 2012

Door-to-Balloon Time and Long-term clinical outcome in patients with STEMI undergoing Primary PCI in Japan

Presentation TCT 2012

Door-to-Balloon Time and Long-term clinical outcome in patients with STEMI undergoing Primary PCI in Japan

Presenter: Hiroki Shiomi, Yoshihisa Nakagawa, Takeshi Morimoto, Yutaka Furukawa, Akira Nakano, Shinichi Shirai, Ryoji Taniguchi, Kyohei Yamaji, Kazuya Nagao, Tamaki Suyama, Hirokazu Mitsuoka, Makoto Araki, Hiroyuki Takashima, Tetsu Mizoguchi, Hiroshi Eisawa, Seigo Sugiyama, Takeshi Kimura

January 03, 2012

Clinical impact of renal function recovery after contrast induced nephropathy on long-term adverse event.

Presentation TCT 2012

Clinical impact of renal function recovery after contrast induced nephropathy on long-term adverse event.

Presenter: Hyuck Jun Yoon, Ji Hyun Sohn, Ho Myung Lee, Hyun ok Cho, Hong Won Shin, Yun-Kyeong Cho, Hyoung-Seob Park, Hyungseop Kim, Chang-Wook Nam, Seung Ho Hur, Yoon-Nyun Kim, Kwon Bae Kim

January 03, 2012

Contrast Induced Nephropathy in Patients With Normal Renal Function Undergoing Complex PCI with High Dose of Contrast Media : Predictive Value of Cystatin C

Presentation TCT 2012

Contrast Induced Nephropathy in Patients With Normal Renal Function Undergoing Complex PCI with High Dose of Contrast Media : Predictive Value of Cystatin C

Presenter: Norbert Mayaud, Karl Isaaz, Christophe Mariat, Alexis Cerisier, Michel Lamaud, Laure Richard, Antoine Da Costa

January 03, 2012

Percutaneous Transcatheter Pulmonary Valve Implantation Induces a Reduction of B-Type Natriuretic Peptide at 30 days.

Presentation TCT 2012

Percutaneous Transcatheter Pulmonary Valve Implantation Induces a Reduction of B-Type Natriuretic Peptide at 30 days.

Presenter: Joelle Kefer, Thierry Sluysmans, St?phane Moniotte, Jean-Marie Gapira, Christophe Beauloye, Agnes Pasquet

January 03, 2012

test 2 slide - server migration

Presentation

test 2 slide - server migration

September 09, 2000

TAVR SESSION: Pure Aortic Regurgitation

Presentation

TAVR SESSION: Pure Aortic Regurgitation

Presenter: Damiano Regazzoli

February 12, 0020

Impact of On-site Cardiac Surgery on Clinical Outcomes After Transfemoral TAVR

Presentation

Impact of On-site Cardiac Surgery on Clinical Outcomes After Transfemoral TAVR

November 09, 0018

Presentation

Everolimus-Eluting Versus Novolimus-Eluting Bioresorbable Scaffolds for CAD

Presenter: Jens Wiebe

February 16, 0017

Quality-of-life Outcomes After TAVR in an Unselected Population

Presentation

Quality-of-life Outcomes After TAVR in an Unselected Population

Presenter: Suzanne Arnold

February 06, 0017

Advertisement

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.